Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 6;25(3):684.
doi: 10.3390/molecules25030684.

Synthesis of Functionalized Cannabilactones

Affiliations

Synthesis of Functionalized Cannabilactones

Yingpeng Liu et al. Molecules. .

Abstract

A new approach to synthesize cannabilactones using Suzuki cross-coupling reaction followed by one-step demethylation-cyclization is presented. The two key cannabilactone prototypes AM1710 and AM1714 were obtained selectively in high overall yields and in a lesser number of synthetic steps when compared to our earlier synthesis. The new approach expedited the synthesis of cannabilactone analogs with structural modifications at the four potential pharmacophoric regions.

Keywords: CB2 selective ligands; Suzuki cross-coupling; cannabilactones; cannabinoids.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A), structures of AM1710 and AM1714 and potential pharmacophores of the cannabilactone template. (B), representative tetrahydrocannabinol (THC) and hexahydrocannabinol (HHC) analogs with the well-defined pharmacophoric regions.
Scheme 1
Scheme 1
Earlier synthesis of AM1710 and AM1714 (6–7 steps, 27–38% overall yields) a. a Reagents and conditions: (a) Diisopropylamine, Et3N, CH2Cl2, rt, 2 h, 75% [26]; (b) i. sec-BuLi, N,N,N′,N′-tetramethylethylenediamine (TMEDA), THF, −78 °C, 1 h; ii. B(OCH3)3, −78 °C to rt, 12 h; iii. 5% aq. HCl, 96%; (c) Br2, CCl4, 0 °C, 20 min, 85%; (d) Pd(Ph3P)4, Ba(OH)2, DME/H2O, 110 °C, microwave irradiation, 15 min, 83%; (e) 9-iodo-9-BBN, CH2Cl2, 0 °C, 4 h; (f) AcOH, reflux, 5 h, 76% from 8; (g) BBr3, CH2Cl2, reflux, 12 h, 72%.
Scheme 2
Scheme 2
New synthesis of functionalized cannabilactones.
Scheme 3
Scheme 3
Synthesis of AM1710, AM1714, and C3 side chain modified cannabilactones (ag) a. a Reagents and conditions: (a) i. n-BuLi, THF, −78 °C, 45 min, 10 °C, 1.5 h, −78 °C 30 min; ii. B(OMe)3, −78 °C to rt, overnight; iii. 5% aq. HCl, 88% for 13, 65% for 17, 80% for 21, 73% for 25, 61% for 30, and 61% for 35; (b) Cs2CO3, DME/H2O, Pd(Ph3P)4, 110 °C, microwave irradiation, 45 min, 84% for 15, 69% for 18, 81% for 22, 76% for 26, 84% for 31, and 83% for 38; (c) 9-iodo-9-BBN, CH2Cl2, 0 °C to rt, overnight, 78% for AM1710, 75% for 19, 70% for 23, 67% for 27, 68% for 32, and 73% for 39; (d) BBr3, CH2Cl2, 2 days, reflux, 74% for AM1714; (e) NaCN, DMSO, rt, overnight, 90%; (f) AgNO3, CH3CN, rt, 5 h, 91%; (g) TIPSOTf, 2,6-lutidine, DCM, 0 °C to rt, 2 h, 89% (h) TBAF, THF, rt, 2 h, 90%; (i) 1-adamantanol, MeSO3H, 50 °C, 3 h, 58%; (j) Tf2NPh, Et3N, 4-(dimethylamino)pyridine (DMAP), CH2Cl2, reflux, 18 h, 95%; (k) PdCl2(Ph3P)2, dppp, n-Bu3N, HCOOH, polymethylhydrosiloxan (PMHS), DMF, reflux, 19 h, 92%.
Scheme 4
Scheme 4
Synthesis of C9/C11 and C1 modified cannabilactones (ae) a. a Reagents and conditions: (a) Cs2CO3, DME/H2O, Pd(Ph3P)4, 110 °C, microwave irradiation, 45 min, 82% for 45, 81% for 48, 80% for 50, 62% for 54, 86% for 59; (b) 9-iodo-9-BBN, DCM, 0°C to rt, overnight, 65% for 46, 75% for 49, 73% for 55, 60% for 60; (c) K2CO3, CD3I, DMF, 0 °C to rt, 3 h, 86%; (d) BBr3, CH2Cl2, −78 °C to rt, overnight, 68%; (e) FeSO4·7H2O, CH2Cl2, MeOH, EtOH, or propan-2-ol, 130 °C, microwave, 1 h, 97–99% for 52a52c; (f) n-Bu4N+N3, CH2Cl2, rt, 2 days, 96% for 52d; (g) MOMCl, DIPEA, CH2Cl2, 0 °C to rt, 1 h, 92%; (h) DABSO, PdCl2(Amphos)2, Et3N, propan-2-ol, 75 °C, 24 h, then NFSI, rt, 3 h, 71%; (i) Sc(OTf)3, EtOH/CH3CN, rt, 8 h, 91%; (j) MOMCl, DIPEA, CH2Cl2, 0 °C to rt, overnight, 98%; (k) TBAF, THF, 0 °C to rt, 30 min, 97%.
Scheme 5
Scheme 5
Synthesis of AM4089 and thiocannabilactone (a,b) a. a Reagents and conditions: (a) CH3MgBr, Et2O/THF, reflux, 2 h; p-TsOH·H2O, CHCl3, rt, 12 h, 65% from 39; (b) TIPSOTf, 2,6-lutidine, CH2Cl2, 0 °C to rt, 2 h, 89%; (c) Lawesson reagent, toluene, reflux, 24 h, 76%; (d) TBAF, THF, −40 °C, 30 min, 82%.

Similar articles

Cited by

References

    1. Pacher P., Batkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 2006;58:389–462. doi: 10.1124/pr.58.3.2. - DOI - PMC - PubMed
    1. Makriyannis A. 2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: A personal perspective. J. Med. Chem. 2014;57:3891–3911. doi: 10.1021/jm500220s. - DOI - PMC - PubMed
    1. Woodhams S.G., Chapman V., Finn D.P., Hohmann A.G., Neugebauer V. The cannabinoid system and pain. Neuropharmacology. 2017;124:105–120. doi: 10.1016/j.neuropharm.2017.06.015. - DOI - PMC - PubMed
    1. Guindon J., Hohmann A.G. The endocannabinoid system and cancer: Therapeutic implication. Br. J. Pharmacol. 2011;163:1447–1463. doi: 10.1111/j.1476-5381.2011.01327.x. - DOI - PMC - PubMed
    1. Console-Bram L., Marcu J., Abood M.E. Cannabinoid receptors: Nomenclature and pharmacological principles. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2012;38:4–15. doi: 10.1016/j.pnpbp.2012.02.009. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources